Literature DB >> 20562649

Newborn screening for hermansky-pudlak syndrome type 3 in Puerto Rico.

Maribel Torres-Serrant1, Sonia I Ramirez, Carmen L Cadilla, Gilberto Ramos-Valencia, Pedro J Santiago-Borrero.   

Abstract

BACKGROUND: Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by albinism, mucocutaneous bleeding, and storage of ceroid material in macrophages. Patients who are not easily identified by physical characteristics (mostly HPS-3 patients) may have hemorrhagic complications with trauma or surgery.
OBJECTIVE: To determine the prevalence of HPS-3 in Puerto Rican newborns using DNA pooling technique. DESIGN/
METHODS: Twelve percent of annual Puerto Rican births were tested randomly by polymerase chain reaction for the HPS-3 mutation, using pooled DNA extracted from dried blood samples.
RESULTS: HPS-3 mutation was detected in 75 samples. Two newborns were found to be homozygous. Carrier frequency was 1:85 (1.18%).
CONCLUSIONS: The HPS-3 carrier frequency found (1.18%) justifies universal newborn screening in Puerto Rico. DNA pooling reduces time and labor in newborn screening thus facilitating early diagnosis and treatment of children with HPS-3 and the provision of genetic counseling to parents and relatives.

Entities:  

Mesh:

Year:  2010        PMID: 20562649      PMCID: PMC3640623          DOI: 10.1097/MPH.0b013e3181e5e1f1

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  19 in total

Review 1.  Molecular genetic testing in pediatric practice: A subject review. Committee on Genetics.

Authors: 
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

Review 2.  DNA Pooling: a tool for large-scale association studies.

Authors:  Pak Sham; Joel S Bader; Ian Craig; Michael O'Donovan; Michael Owen
Journal:  Nat Rev Genet       Date:  2002-11       Impact factor: 53.242

3.  Albinism and Hermansky-Pudlak syndrome in Puerto Rico.

Authors:  C J Witkop; M Nuñez Babcock; G H Rao; F Gaudier; C G Summers; F Shanahan; K R Harmon; D Townsend; H O Sedano; R A King
Journal:  Bol Asoc Med P R       Date:  1990-08

4.  Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome.

Authors:  C J Witkop; M Krumwiede; H Sedano; J G White
Journal:  Am J Hematol       Date:  1987-12       Impact factor: 10.047

5.  Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency.

Authors:  M Huizing; Y Anikster; D L Fitzpatrick; A B Jeong; M D'Souza; M Rausche; J R Toro; M I Kaiser-Kupfer; J G White; W A Gahl
Journal:  Am J Hum Genet       Date:  2001-10-03       Impact factor: 11.025

6.  Hermansky-Pudlak syndrome with granulomatous colitis.

Authors:  R A Schinella; M A Greco; B L Cobert; L W Denmark; R P Cox
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

Review 7.  Hermansky-Pudlak syndrome: vesicle formation from yeast to man.

Authors:  Marjan Huizing; Raymond E Boissy; William A Gahl
Journal:  Pigment Cell Res       Date:  2002-12

8.  Physiogenomic analysis of the Puerto Rican population.

Authors:  Gualberto Ruaño; Jorge Duconge; Andreas Windemuth; Carmen L Cadilla; Mohan Kocherla; David Villagra; Jessica Renta; Theodore Holford; Pedro J Santiago-Borrero
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

9.  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1).

Authors:  Wei Li; Qing Zhang; Naoki Oiso; Edward K Novak; Rashi Gautam; Edward P O'Brien; Caroline L Tinsley; Derek J Blake; Richard A Spritz; Neal G Copeland; Nancy A Jenkins; Dominick Amato; Bruce A Roe; Marta Starcevic; Esteban C Dell'Angelica; Rosemary W Elliott; Vishnu Mishra; Stephen F Kingsmore; Richard E Paylor; Richard T Swank
Journal:  Nat Genet       Date:  2003-08-17       Impact factor: 38.330

10.  Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome.

Authors:  K R Harmon; C J Witkop; J G White; R A King; M Peterson; D Moore; J Tashjian; W A Marinelli; P B Bitterman
Journal:  J Lab Clin Med       Date:  1994-04
View more
  5 in total

1.  Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3).

Authors:  Javier Jardón; Natalio J Izquierdo; Jessica Y Renta; Omar García-Rodríguez; Carmen L Cadilla
Journal:  Ophthalmic Genet       Date:  2014-04-28       Impact factor: 1.803

2.  Prevalence of a loss-of-function mutation in the proton-coupled folate transporter gene (PCFT-SLC46A1) causing hereditary folate malabsorption in Puerto Rico.

Authors:  Kris M Mahadeo; Ndeye Diop-Bove; Sonia I Ramirez; Carmen L Cadilla; Enid Rivera; Madelena Martin; Norma B Lerner; Lisa DiAntonio; Salvatore Duva; Pedro J Santiago-Borrero; I David Goldman
Journal:  J Pediatr       Date:  2011-04-13       Impact factor: 4.406

3.  Dermatologic manifestations in patients with the Hermansky-Pudlak syndrome types 1 and 3.

Authors:  Gabriel Santos Malave; Natalio J Izquierdo; Nestor P Sanchez
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

4.  Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene.

Authors:  Dina Marek-Yagel; Shachar Abudi-Sinreich; Michal Macarov; Alvit Veber; Nechama Shalva; Amit Mary Philosoph; Ben Pode-Shakked; May Christine V Malicdan; Yair Anikster
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

5.  Hermansky-Pudlak syndrome: Mutation update.

Authors:  Marjan Huizing; May C V Malicdan; Jennifer A Wang; Hadass Pri-Chen; Richard A Hess; Roxanne Fischer; Kevin J O'Brien; Melissa A Merideth; William A Gahl; Bernadette R Gochuico
Journal:  Hum Mutat       Date:  2020-01-23       Impact factor: 4.700

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.